RT Journal Article
T1 Opinions towards Key Operational Aspects for the Implementation of HIV Self-Testing in Spain: A Comparison between Stakeholders and Potential Users
A1 Hoyos Miller, Juan Eduardo
A1 Guerras, Juan Miguel
A1 Maté, Tomás
A1 Agustí, Cristina
A1 Fernández López, Laura
A1 Fuente, Luis de la
A1 Belza, María-José
AB We assessed previous knowledge about the existence of HIV self-testing of stakeholders in Spain, as well as their personal position towards this methodology. We also assessed their views on potential users’ (PU) opinions towards several key operational aspects surrounding self-testing, and compared them to those expressed by a sample of PU comprised of men who have sex with men. In 2017, we recruited three types of stakeholders: public health professionals and policy makers (PHPPM) (n = 33), clinical providers (n = 290) and community-based/non-governmental organization (CBO/NGO) workers (n = 55). Data on PU (n = 3537) were collected in 2016. Previous knowledge about the existence of self-testing was higher in stakeholders than in PU, but being in favor was less frequent. PUs’ willingness to pay 25–30 euros for a self-test was higher than that which stakeholders considered. According to clinical providers and PHPPM, pharmacies would be PUs’ preferred place to obtain a self-test, which was in line with PUs’ actual choice. CBO/NGO workers on the other hand thought it would be CBO/NGOs. PHPPM and clinical providers considered primary care as PUs’ preferred setting to confirm a reactive self-test and CBO/NGO chose CBO/NGOs, but PUs preferred an HIV/STI testing service or clinic. Stakeholders’ opinions significantly differed from those of PUs. This divergence needs to be brought up to stakeholders as it could vary their position towards self-testing as well as the actions taken in the implementation of a testing option with the potential of increasing testing frequency.
PB MPDI
SN 1660-4601
YR 2021
FD 2021-01-30
LK https://hdl.handle.net/20.500.14352/6913
UL https://hdl.handle.net/20.500.14352/6913
LA eng
NO Consumers, Health and Food Executive Agency
NO Instituto de Salud Carlos III (ISCIII)
DS Docta Complutense
RD 4 abr 2025